CSL - Debt

Stock Price
128.90
Daily Change
-2.92 -2.22%
Monthly
-8.46%
Yearly
-47.48%
Q2 Forecast
127.56

CSL reported $11.96B in Debt for its fiscal semester ending in December of 2024.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 1.84M 8K Sep/2025
Bio Path USD 261K 261K Mar/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
TherapeuticsMD USD 93.6M 2.82M Sep/2022